A Pilot Study of Microbiome in Patients With Autism Spectrum Disorder and Their Unaffected Siblings
1 other identifier
observational
150
1 country
1
Brief Summary
The primary aims are to identify important gut microbiota signatures for youth with ASD, to identify dysbiosis features for different levels of ASD features and clinical courses, to search the possibility to intervene the disease course if we can tease out the dysbiosis responsible for the flare-up and improvement of the symptoms of the disease. The secondary aims are to identify the clinical and neuropsychological measures that are associated with direct and indirect regulation or interactions from gut-brain axis signaling, and based our preliminary results on reducing the measures for future large-scale microbiome study in ASD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2020
CompletedFirst Submitted
Initial submission to the registry
September 1, 2021
CompletedFirst Posted
Study publicly available on registry
September 9, 2021
CompletedSeptember 16, 2021
January 1, 2021
2 years
September 1, 2021
September 8, 2021
Conditions
Outcome Measures
Primary Outcomes (2)
Autism Diagnostic Interview-Revised (ADI-R)
Including reciprocal social interaction, communication, and repetitive behaviors and stereotyped patterns, for children with a mental age from about 18 months into adulthood. The coding of some items is converted to numeric scores "0" if no evidence of abnormality exists, "1" if some evidence of abnormality exists, and "2" if evidence of marked abnormality. Higher scores mean more severe clinical deficits.
1 hour
Autism Diagnostic Observation Scale (ADOS)
Including communication, social interaction, creativity, stereotyped behaviors and restricted interests. The coding of some items is converted to numeric scores "0" if no evidence of abnormality exists, "1" if some evidence of abnormality exists, and "2" if evidence of marked abnormality. Higher scores mean more severe clinical deficits.
1 hour
Study Arms (3)
ASD group
80 youths with the clinical diagnosis of ASD according to the DSM-5 diagnostic criteria
Sibling group
30 unaffected siblings of ASD youths
TD group
40 healthy typical developing(TD) control from cohort established at Department of Psychiatry, National Taiwan University Hospital (NTUH) starting from 2007
Interventions
Kiddie Schedule for Affective Disorders \& Schizophrenia (K-SADS) for DSM-5
Autism Diagnostic Interview-revised (ADI-R) and Autism Diagnostic Observation Scale (ADOS)
Eligibility Criteria
The cohort was established at the Department of Psychiatry, National Taiwan University Hospital (NTUH) starting from 2007.
You may qualify if:
- a clinical diagnosis of ASD defined by the DSM-IV confirmed by ADI-R or ADOS and also clinical reappraisal based on the newly release DSM-5 criteria for ASD
- ages range from 7 to 25 at the time now
- at least one biological parent
- parents that are both Han Chinese in Taiwan
You may not qualify if:
- intellectual disability
- epilepsy
- ADHD
- autoimmune diseases
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan Univeristy Hospital
Taipei, Taiwan
Biospecimen
5 g of stool sample
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 1, 2021
First Posted
September 9, 2021
Study Start
January 1, 2019
Primary Completion
December 31, 2020
Study Completion
December 31, 2020
Last Updated
September 16, 2021
Record last verified: 2021-01